会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Methods for cyclizing synthetic polymers
    • 环合合成聚合物的方法
    • US20050282736A1
    • 2005-12-22
    • US11136806
    • 2005-05-24
    • Todd Kinsella
    • Todd Kinsella
    • A61K38/00A61K38/16C12N15/10C12P19/34C12P21/02C12P21/06G01N33/53
    • C12P19/34A61K38/00C12N15/10C12P21/02
    • The invention provides methods and compositions for production of a cyclic polymer in a cell free system. In general, the methods of the invention involve ligating first and second recombinant intein domains to a linear synthetic polymer to form a compound containing the structure: D1-X(n)-D2, where D1 is a first catalytic domain of an intein; D2 is a second catalytic domain of an intein; where the second catalytic domain has at its N-terminus a first reactive site for the intein; and X(n) is a polymer of a number n of monomer X, where the polymer N-terminus has a second reactive site for the intein. D1-X(n)-D2 compounds autocatalytically cyclize the X(n) polymer to produce a cyclic polymer. The invention finds use in a variety of drug discovery, clinical and therapeutic applications.
    • 本发明提供了在无细胞体系中生产环状聚合物的方法和组合物。 通常,本发明的方法涉及将第一和第二重组内含肽结构域连接到线性合成聚合物以形成含有以下结构的化合物:D 1 -X(n) 其中D 1是内含肽的第一催化结构域; D 2是内含肽的第二催化结构域; 其中第二催化结构域在其N末端具有用于内含肽的第一反应位点; 且X(n)是数量为n的单体X的聚合物,其中聚合物N末端具有用于内含肽的第二反应位点。 化合物自由催化地使X(n)聚合物环化,从而产生一个(N) 环状聚合物。 本发明可用于各种药物发现,临床和治疗应用。
    • 9. 发明授权
    • Rapid, stable high-titre production of recombing retrovirus
    • 快速,稳定的高滴度生产推荐逆转录病毒
    • US5830725A
    • 1998-11-03
    • US430813
    • 1995-04-28
    • Garry P. NolanTodd Kinsella
    • Garry P. NolanTodd Kinsella
    • C12N15/867C12N15/00A61K48/00C07K14/00C12N5/00
    • C12N15/86C12N2740/13043
    • High titre helper-free recombinant retrovirus are produced by (a) growing a transfected host cell, produced by transfecting a eukaryotic host cell with a recombinant vector capable of stable episomal maintenance in the host cell, in a medium under conditions whereby the recombinant vector is stably maintained as an episome in the transfected host cell and transcripts of said vector form, with retroviral gag, pol and env gene products, an infectious retrovirus; and (b) isolating from the medium helper-free infectious retrovirus formed in the transfected host cell. The recombinant vectors comprise (i) a retroviral construct comprising an exogenous gene; (ii) a eukaryotic origin of replication sequence providing a substrate for replicase activity capable of replicating the vector in the host cell; and, (iii) a copy control sequence providing a substrate for a copy control activity capable of maintaining the vector at a stable copy number in the host cell. The transfected host cell provides retroviral pol reverse transcriptase and integrase activity, the replicase activity and copy control activity, as well as retroviral gag and env gene products capable of forming, with a transcript of the retroviral construct, an infectious retrovirus.
    • 通过以下步骤制备高滴度无辅助重组逆转录病毒:(a)通过在培养基中培养转染的宿主细胞,所述转染的宿主细胞通过在宿主细胞中能够稳定的附加型维持的重组载体转染真核宿主细胞而产生, 在转染的宿主细胞中稳定地维持该转录物和所述载体形式的转录物,其具有逆转录病毒gag,pol和env基因产物,感染性逆转录病毒; 和(b)从转染的宿主细胞中形成的中等无辅助感染性逆转录病毒分离。 重组载体包含(i)包含外源基因的逆转录病毒构建体; (ii)提供能够复制宿主细胞中的载体的复制酶活性的底物的真核复制起点序列; 和(iii)复制控制序列,其提供能够将载体维持在宿主细胞中稳定拷贝数的拷贝控制活性的底物。 转染的宿主细胞提供逆转录病毒pol逆转录酶和整合酶活性,复制酶活性和拷贝对照活性,以及​​能够与逆转录病毒构建体的转录物形成感染性逆转录病毒的逆转录病毒gag和env基因产物。